Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol with low-dose alfentanil for painless transesophageal echocardiography
ChiCTR2400081723Phase 4Not yet recruiting
- Sponsor
- Xiamen Cardiovascular Hospital
- Start
- Mar 2024
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ciprofol, propofol and alfentanil in cardiac disease and cardiac morbidity (2 arms), sponsored by Xiamen Cardiovascular Hospital. Primary endpoints: Sedation-related adverse events and Cough reflex. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
ciprofolpropofolalfentanil
03
Conditions
cardiac diseasecardiac morbidity
Beyond the preview
Go deeper on ChiCTR2400081723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081723.